Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-blinded Multi-center Study of Efficacy and Safety of Lipocet® in Patients With Primary Knee Osteoarthritis Grade 3 - 4

NCT06134115 is registered in ClinicalTrials.gov with Pharmanutra S.p.a. as lead sponsor.

NCT NCT06134115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06134115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-blinded Multi-center Study of Efficacy and Safety of Lipocet® in Patients With Primary Knee Osteoarthritis Grade 3 - 4
Lead sponsor
Pharmanutra S.p.a.
Phase
Not applicable
Overall status
Completed
Start date
August 19, 2022
Completion date
May 18, 2023
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary knee osteoarthritis grade 3 - 4